Life Sciences

About

Provided by Mori Hamada & Matsumoto

MHM was one of the first Japan-based law firms to establish a practice group dedicated to the life sciences, including health care, pharmaceuticals and medical sciences, and is now without doubt a market leader in this area. Our group practitioners comprise mostly of young and dynamic partners and associates who are attuned to emerging technologies. Its life sciences practice encompasses a wide range of legal matters, from regulatory issues to intellectual property to crisis management to mergers and acquisitions to financing to corporate restructurings, among others. Our lawyers regularly deal with the manufacture, importation and distribution of medical and pharmaceutical products and equipment, governmental approvals, strategic alliances, investments in bio-ventures, and specific regulatory and corporate governance issues affecting medical institutions. Consequently, we are regularly chosen by a wide range of pharmaceutical companies, medical device companies, and biotech start-ups, both domestic and foreign, to advise them on a wide range of legal issues related to their operations.  Our experience has created a solid group of legal practitioners who are well-versed not only in the complex and constantly evolving laws and regulations affecting this important and expanding industry but in the specific, practical characteristics and needs of the industry as well.